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Proteomic proﬁlesRecently, Candida rugosa was characterized as a species complex comprising four taxa: C. rugosa sensu
stricto, Candida pseudorugosa, Candida neorugosa and Candida mesorugosa. Although considered relatively
rare, several clusters of candidemia due to C. rugosa complex had been reported presenting mortality
rates close to 70%. In this work we discuss the systematization, phenotyping and molecular methods
based on internal transcribed spacer region (ITS) sequencing and proteomic analyses for species identi-
ﬁcation, as well as clinical aspects of the C. rugosa complex. We performed a Bayesian phylogenetic anal-
ysis using 72 ITS sequences representative of C. rugosa complex isolates and related species within the
genus. Biochemical, morphological and MALDI-TOF MS analyses were processed with C. rugosa complex
type strains and related species isolates. We described that the phylogeny showed four distinct clades
inferred with high posterior probabilities, corresponding to the four species within the C. rugosa complex,
excluding C. pararugosa. Biochemical and morphological aspects distinguished only C. rugosa sensu stricto
but were not sufﬁcient to accurately identify species within the rest of the complex. Protein spectrum
proﬁles differentiated all reference strains from different species analyzed. To our knowledge, we pre-
sented the ﬁrst phylogenetic analysis using a large collection of ITS sequences as well as proteomic pro-
ﬁles generated from isolates of the C. rugosa complex and related species that can enlighten systematics,
diagnostics and clinical research ﬁelds.
 2013 Elsevier Inc. All rights reserved.1. Introduction studied as a source of extracellular lipases that can be used in theCandida rugosa is an ascomycetous yeast organism that appears
to be emerging as an etiological agent of human infectious diseases
in different parts of the world (Pfaller et al., 2006). This species is
most frequently found in environmental sources and is a cause of
bovine mastitis, which is one of the most important diseases in
dairy cows (Crawshaw et al., 2005; Scaccabarozzi et al., 2011).
However, in recent years, C. rugosa has been described as a cause
of candidemia in critically ill trauma patients (Behera et al.,
2010; Pfaller et al., 2006; Singh et al., 2011), with the isolation fre-
quency estimated at 0.6% worldwide, but a higher prevalence in
South America (2.7%) (Pfaller et al., 2006).
Candida rugosa is phenotypically characterized by the formation
of macroscopic wrinkled colonies that vary in color from white to
cream and microscopic blastoconidia and pseudohyphae (De Hoog
et al., 2000). This species is an anamorph yeast without a described
sexual cycle (Calderone and Clancy, 2012). It has been extensivelyproduction of several compounds, such as fatty acids and esters
(Benjamin and Pandey, 1998; Dominguez de Maria et al., 2006).
Historically, C. rugosa was ﬁrst named Mycoderma rugosa by
Anderson after isolation from human feces in 1917 (Moretti
et al., 2000). It possessed species synonymies in the botanical ﬁeld
for decades, known as Azymocandida rugosa,Mycotorula rugosa and
Torula rugosa. Finally, in 1942, C. rugosawas reclassiﬁed by Diddens
and Lodder (Meyer et al., 1998).
In recent years, with the knowledge gained from molecular
studies, systematic and taxonomic classiﬁcations of molds and
yeasts have been dramatically revised. Candida rugosa is now
addressed as a complex of different species that encompasses
C. rugosa, C. pseudorugosa, C. neorugosa and C. mesorugosa (Chaves
et al., 2013; Paredes et al., 2012).
Due to the novelty of the molecular characterization of cryptic
species within the C. rugosa complex, there is a lack of robust
and consistent data on the putative clinical peculiarities and anti-
fungal susceptibility of all four species. Consequently, most of the
publications on human infections caused by strains of the C. rugosa
complex had not provided accurate identiﬁcation of species by
gene sequencing (Colombo et al., 2003; Minces et al., 2009).
In the three largest series of candidemia due to the C. rugosa
complex, crude mortality rates ranged from 44% to 68% (Behera
et al., 2010; Colombo et al., 2003; Dube et al., 1994). It remains
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hematogenous infections are mostly related to the severity of
illness and comorbidities present at the time of the diagnosis of
fungemia or whether this ﬁnding may be related to the limited
antifungal susceptibility of C. rugosa to amphotericin B and ﬂuco-
nazole (Behera et al., 2010; Colombo et al., 2003).
In addition to hematogenous candidiasis, yeasts of the C. rugosa
complex have been rarely isolated from the respiratory tract, urine,
feces, skin and peritonitis (Kocyigit et al., 2010; Li et al., 2006;
Paredes et al., 2012; Tay et al., 2011).
Authors had little success in demonstrating that C. rugosa
isolates produce virulence factors, e.g., secreted enzymes. Among
different species of Candida spp. tested, C. rugosa isolates were neg-
ative for phospholipase and protease activities (Kantarcioglu and
Yucel, 2002), and could only produce alpha hemolysis (Luo et al.,
2001). Lipase secretion by C. rugosa strains has been extensively
investigated, and these enzymes have many applications in bio-
technological processes (Benjamin and Pandey, 1998; Dominguez
de Maria et al., 2006). However, it remains unclear whether C. rug-
osa secreted lipases have any relevance to colonization or infection
in human hosts, suggesting that C. rugosa complex is one of the less
virulent of the genus.
The focus of the present work is to review taxonomic and diag-
nostic aspects of the C. rugosa sensu lato providing new data related
to proteomic proﬁles as well as a phylogenetic approach to enlight-
en the systematics of the species within this complex.2. Material and methods
2.1. Phylogenetic analysis
To perform the phylogenetic analysis, ITS sequences were
downloaded from GenBank (http://www.ncbi.nlm.nih.gov/
genbank/) after BLASTn searches (http://blast.ncbi.nlm.nih.gov/
Blast.cgi) using the sequences from type strains of each species
within the C. rugosa complex and C. pararugosa as queries: C. rugosa
CBS 613T or ATCC 10571T (AY500374), C. mesorugosa CBS 12656T
(FJ768909), C. pseudorugosa CBS 10433T (DQ234792), C. neorugosa
CBS 12627T (HE716762) and C. pararugosa ATCC 38774T
(AF421856). Only sequences that presented identity and coverage
of P80% with query sequences with low levels of gaps and/or
ambiguities were considered in the analysis, to include a more rep-
resentative sample of interspecies and intraspecies variations
(Ciardo et al., 2006; Nilsson et al., 2008). Additionally, the ITS
sequences of C. albicans (FJ662406), C. dubliniensis (AB369916),
C. parapsilosis (EU564205), C. metapsilosis (EU484054) and
C. orthopsilosis (EU557373), that represent well-known species
complexes were added for comparison. All sequences were aligned
using the muscle algorithm implemented by SEAVIEW 4.2.12
(Gouy et al., 2010) and adjusted by eye before phylogenetic
analysis. An unconstrained consensus phylogeny was inferred with
MrBayes (Huelsenbeck and Ronquist, 2001; Ronquist and
Huelsenbeck, 2003) with default priors as input. The number of
generations was 2.5 million, where the average standard deviation
of split frequencies was <0.01, with data saved every 100 genera-
tions and run in four chains and two runs. During the runs, the
GTR model and shape of the gamma distribution parameters, as
well as the proportions of invariant sites, were estimated.2.2. Phenotypic and biochemical characterization of the C. rugosa
species complex and related species
The colony morphology of C. rugosa ATCC 10571T, C. mesorugosa
CBS 12656T, C. pseudorugosa CBS 10433T, C. neorugosa CBS 12627T,
and C. rugosa (pararugosa) CBS 1948T was determined onSabouraud Dextrose Agar (SDA) (BD Difco, USA) plates after 48 h
of incubation at 35 C. CHROMagar Candida (BD, USA) plates were
incubated at 35 C for 72 h before colony color observation. For
micromorphological observation, cells were cultured in Yeast Pep-
tone Dextrose (YPD) broth and incubated overnight at 30 C and
also in cornmeal agar plates incubated at 35 C for 72 h. For bio-
chemical and assimilation analyses, ID32C (BioMerieux, France)
was used according to the manufacturer’s instructions.2.3. Mass spectrometry analysis of the Candida rugosa complex and
related species
All tested Candida sp. isolates were recovered from frozen stock
onto SDA and incubated for 3 days at 35 C before experiments. To
obtain the proteins from the isolates, we ﬁrst tested the protocol
described by Stevenson et al. (2010), but we found that C. rugosa
ATCC 10571T, which formed very wrinkled colonies, and C. rugosa
(C. pararugosa) CBS 1948T did not yield reproducible results. There-
fore, we adapted the protocol by growing the isolates in YPD broth
overnight at 30 C before proceeding with the analysis. One millili-
ter of cultured cells was pelleted and washed twice with ultrapure
water, and the excess of water was removed. A small loop of cells
was directly spotted onto each position of a Micro Scout Plate
(MSP) 96 polished steel target (Bruker Daltonics GmbH, Germany).
Then, 25% formic acid was immediately poured onto the samples.
After drying at room temperature, each sample was overlaid with
matrix solution, which consisted of a saturated solution of alpha-
cyano-4-hydroxy-cinnamic acid (Sigma, USA) in 50% acetonitrile/
2.5% triﬂuoroacetic acid (Sigma, USA), and the matrix/sample was
co-crystallized by air-drying at room temperature. Each isolate
was spotted in triplicate. Measurements were performed with a
Microﬂex LT mass spectrometer (Bruker Daltonics) using FlexCon-
trol software (version 3.0, BrukerDaltonics). Spectra were recorded
in the positive linear mode (laser frequency, 20 Hz; ion source
1 voltage, 20 kV; ion source 2 voltage, 18.6 kV; lens voltage,
7.5 kV; mass range, 2000–20,000 Da). For each spectrum, 100 shots
in 50-shot steps from different positions of the target spot (auto-
matic mode) were collected and analyzed. Spectra were internally
calibrated by using Escherichia coli ribosomal proteins. MALDI Bio-
typer software 3.0 (Bruker Daltonik GmbH) was used to visualize
mass spectra and generate the MSP dendrogram.3. Results and discussion
3.1. Taxonomy, systematics and geographic trends of different species
within the C. rugosa complex
In the past years, the high genetic heterogeneity of the C. rugosa
taxon has gained attention (Dib et al., 1996; Redkar et al., 1996;
Scaccabarozzi et al., 2011; Tay et al., 2011), and more studies on
the morphology, biochemical patterns and sequencing analysis,
mostly based on ribosomal RNA genes, have impacted the taxon-
omy of C. rugosa.
The novel species within the C. rugosa complex have been iden-
tiﬁed based on 26S D1/D2 rDNA sequences, complemented with
ITS sequences (Butinar et al., 2011; Chaves et al., 2013; Li et al.,
2006; Paredes et al., 2012; Taverna et al., 2012; Tay et al., 2011).
Of note, only C. mesorugosa was characterized based on sequences
of rDNA regions as well as housekeeping genes (Chaves et al.,
2013).
To our knowledge, no complete genome of any species within
the C. rugosa complex is available. Chaves et al. (2013) succeeded
in amplifying fragments of ACT1 and COX2 of C. rugosa, C. mesorug-
osa and C. pseudorugosa, but the RBP1 gene fragment could not be
ampliﬁed from one of the C. pseudorugosa-like isolates, and none of
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(C. pararugosa) CBS 1948T (Chaves et al., 2013).
The fungal barcoding initiative has recently proposed the use of
ITS sequences to accurate identify fungal species (Schoch et al.,
2012). Therefore, analysis of the ITS region may not only sufﬁce
for those who want rapid species identiﬁcation by sequence com-
parisons with type strains, but also, be applied to infer evolution-
ary relationships among cryptic and newly characterized taxa.
Here, we describe the phylogenetic relationships based on a
comprehensive analysis of ITS sequences obtained from different
strains representative of all species within the C. rugosa complex
and related species (Table 1 and Fig. 1). The C. rugosa species com-
plex includes four distinct clades, inferred with high posterior
probabilities (pp), that corresponded to C. rugosa sensu stricto and
three recently described species: C. pseudorugosa, C. neorugosa
and C. mesorugosa (Fig. 1) (Chaves et al., 2013; Paredes et al.,
2012). Despite C. pseudorugosa and C. neorugosa split had occurred
earlier than C. rugosa sensu stricto and C. mesorugosa, the ﬁrst two
species were considered as part of the C. rugosa complex because
they still can be misidentiﬁed as C. rugosa when only phenotypic
and biochemical characteristics are analyzed.
In our analysis, the C. rugosa sensu stricto clade was divided into
two distinct groups with a pp of 0.78: group I accounted for strains
mostly isolated from human or animal sources in the United States,
United Kingdom and Thailand and grouped with C. rugosa
ATCC10571T type strain (CBS 613T and WM234), whereas in group
II, the majority of the isolates were from environmental sources,
originally from China and India (Table 1). Tay and collaborators
(2011) have described two C. rugosa subgroups when analyzing se-
quences of rDNA: subgroup A, related to environmental isolates,
and subgroup B, related to clinical isolates (Tay et al., 2011). How-
ever, they observed by BLAST analysis that both ITS and 26S D1/D2
sequences of C. rugosa subgroup B shared greater identity with se-
quences from C. rugosa ATCC 10571T than subgroup A (93.7 and
99.6% versus 89.2 and 99.1, respectively). Indeed, in our analysis,
the ITS sequence from isolate STC4 (subgroup B) grouped with
C. rugosa environmental isolates (C. rugosa group II), whereas the
isolate STC1, which belongs to their subgroup A, clustered within
the clade of the novel species C. mesorugosa (Chaves et al., 2013).
Therefore, STC1 should be acknowledged as a representative of
the C. mesorugosa taxon.
Candida pseudorugosa was described in 2006 (Li et al., 2006),
and it was ﬁrst isolated from a sputum sample of a Chinese patient
who died of respiratory failure, septic shock, and deterioration.
After the original report, two C. pseudorugosa-like isolates recov-
ered in 2001 from subglacial ice in the coastal Arctic environment
of Kongsfjorden, Spitzbergen, were reported (Butinar et al., 2011).
The species identiﬁcation was veriﬁed with sequencing analysis
of the 26S D1/D2 region, and the identity and coverage between
the two environmental isolates and the C. pseudorugosa type strain
sequences were 99% and 100%, respectively. Finally, Taverna et al.
(2012) recently described the isolation of specimens from blood
and central venous catheters of a female patient in Argentina that
were closely related to C. pseudorugosa (Taverna et al., 2012). In our
analysis (Fig. 1), the C. pseudorugosa clade appeared diverse, with
several uncharacterized isolates grouping with the reference strain
and with well-identiﬁed C. pseudorugosa isolates. The sequences
from those uncharacterized isolates might be representatives of
different subspecies, varieties or even novel species within the
C. pseudorugosa clade. However, this hypothesis remains to be con-
ﬁrmed by further analysis of other genes and by increasing the
number of isolates tested to ensure consistency in this clade.
Most recently, two novel C. rugosa-related species were
described: C. neorugosa and C. mesorugosa (Chaves et al., 2013;
Paredes et al., 2012). Candida neorugosa is closest to the
C. pseudorugosa clade and has only three characterized isolatesrelated to clinical sources, two isolated in the USA and one in Brazil.
Candida mesorugosa is another diverse group. In our phylogenetic
analysis, we discriminated two groups: the ﬁrst one grouped
sequences from strains isolated from animal and environmental
sources in Pakistan and India; the second group encompassed strains
isolated from elephant feces from Pakistan with the C. mesorugosa
type strain (CBS 12656T) and other well-characterized clinical isolates
from Brazil. The two groups within the C. mesorugosa clade were
separated with pp = 0.63, suggesting that the intraspeciﬁc variability
of the ITS sequences analyzed was low. Therefore, other DNAmarkers
with faster substitution rates as mitochondrial genes would be useful
to address the phylogenetic relationships of the isolates within the
C. mesorugosa taxon.
Although the C. pararugosa taxon is not part of the C. rugosa
species complex according to molecular analysis, misidentiﬁcation
of this species as C. rugosa is common when only phenotypic char-
acteristics are analyzed. Fig. 1 shows that C. pararugosa is a distinct
clade, with pp = 1. Isolates from different sources and countries can
be found, such as isolates obtained from foods (cheeses and
koumiss) in Spain, Canada and China, and isolates obtained from
clinical sources, mostly from the USA and one isolate from Brazil
(Table 1).
3.2. Limitations of phenotypic tests for accurate identiﬁcation of
species within the C. rugosa complex and related taxa
Although molecular methods are considered the gold standard
for yeast identiﬁcation, morphological and biochemical tests are
still used by most clinical laboratories for Candida sp. identiﬁca-
tion. Below, we present data on morphological aspects of the
colonies and biochemical tests that may be useful in a ﬁrst screen-
ing for species identiﬁcation of the C. rugosa species complex.
3.2.1. Morphological aspects
In our study C. rugosa ATCC 10571T presented white, wrinkled
and fringed colonies on SDA plates (Fig. 2), in accordance with a
previous description by (Meyer et al., 1998). In contrast, C. pseudo-
rugosa CBS 10433T, C. neorugosa CBS 12627T and C. mesorugosa CBS
12656T showed white, smooth colonies, whereas C. pararugosa CBS
1948T presented smaller and ﬂat colony.
By culturing the reference strains on CHROMagar Candida, each
tested species generated different colony colors: dry light blue for
C. rugosa, blue-pink for C. mesorugosa, dark blue for C. pseudorug-
osa, pale pink for C. pararugosa and dark blue-violet for
C. neorugosa.
In terms of micromorphology, the C. rugosa isolate exhibited
abundant pseudohyphae in both YPD broth and cornmeal agar.
Production of pseudohyphae was incipient in C. pseudorugosa and
absent in C. mesorugosa, C. neorugosa and C. pararugosa grown in
YPD broth. On cornmeal agar plates, those four species presented
few and/or rudimentary pseudohyphae and many blastoconidia.
Taken together the ﬁndings considering the type strains, we may
suggest that macro and micromorphological aspects, such as, wrin-
kled and dry aspect of the colony with abundant pseudohyphae,
have a potential for discriminating C. rugosa sensu stricto from
other closely related species. However, more studies using a larger
collection of strains within the C. rugosa complex should be
performed to better support our observations.
3.2.2. Biochemical tests
Candida rugosa is a non-fermentative yeast, so biochemical
assimilation tests are essential to differentiate this species from
other Candida spp. (Meyer et al., 1998). As described by Meyer
et al. (1998), C. rugosa isolates can assimilate glucose (+), galactose
(+), L-sorbose (v), D-xylose (v), N-acetyl-D-glucosamine (late +),
ethanol (+) glycerol (+), ribitol (/late +), D-mannitol (+/late +),
Table 1
Strains and sequences obtained from BLAST comparisons of the C. rugosa species complex analyzed in the present study.
Strain Source/isolation site Country ITS GenBank no. References
C. rugosa ATCC10571T, or Human feces – GU144663 Mota et al. (unpublished), Pryce et al. (2003), Kong et al.
(unpublished)CBS 613T, or AY500374
WM234 EF568037
C. rugosa UTHSC 06-3729 Human ear USA HE716760 Paredes et al. (2012)
C. rugosa CBS 2016 Dung of scouring cow UK GU246265 Groenewald and Smith (2010)
C. rugosa NRRL 95 – USAa AY533550 and
AY533551b
Ren and Chaturvedi. (unpublished)
C. rugosa Z-HS5 Soil Pakistana JF896570 Latif and Amin. (unpublished)
C. rugosa Z-HS13 Soil Pakistana JF896571 Latif and Amin. (unpublished).
Candida sp. 10-1 Elephant feces Thailand AB727605 Lorliam, et al. (unpublished).
C. rugosa STC4 subgroup B Human blood Malaysia HM641832 Tay et al. (2011)
C. rugosa Zhuan8 Marine yeast Chinaa EF197805 Guo and Chi. (unpublished)
C. rugosa strain 8 Marine yeast Chinaa EF198009 Liu and Chi. (unpublished)
C. rugosa strain UY Contaminated soil India JQ974952 Dandi et al. (unpublished)
C. rugosa UTHSC R-3412 Human Spaina HE716759 Paredes et al. (2012)
C. rugosa STC1 subgroup A Human blood Malaysia HM641831 Tay et al. (2011)
C. mesorugosa L69D (CBS12656)T Human blood Brazil FJ768909 Chaves et al. (2013)
C. mesorugosa L154 Human blood Brazil FJ768910 Chaves et al. (2013)
C. mesorugosa L387A Human rectal swab Brazil FJ768911 Chaves et al. (2013)
C. mesorugosa L412D Human pericatheter
swab
Brazil FJ768912 Chaves et al. (2013)
C. mesorugosa L2683B Human blood Brazil FJ768913 Chaves et al. (2013)
C. mesorugosa UOA/HCPF2 Human blood Greece GQ376074 Meyer et al. (unpublished)
Candida sp. 2-1 Elephant feces Thailand AB727593 Lorliam et al. (unpublished)
Candida sp. 3-2 Elephant feces Thailand AB727594 Lorliam et al. (unpublished)
Candida sp. 5-1 Elephant feces Thailand AB727595 Lorliam et al. (unpublished)
Candida sp. 5-2 Elephant feces Thailand AB727598 Lorliam et al. (unpublished)
Candida sp. 5-3 Elephant feces Thailand AB727597 Lorliam et al. (unpublished)
Candida sp. 7-1 Elephant feces Thailand AB727599 Lorliam et al. (unpublished)
Candida sp. 7-8 Elephant feces Thailand AB727600 Lorliam et al. (unpublished)
Candida sp. 9-1 Elephant feces Thailand AB727601 Lorliam et al. (unpublished)
Candida sp. 9-2 Elephant feces Thailand AB727602 Lorliam et al. (unpublished)
Candida sp. 9-3 Elephant feces Thailand AB727603 Lorliam et al. (unpublished)
Candida sp. 9-4 Elephant feces Thailand AB727604 Lorliam et al. (unpublished)
Candida sp. 10-2 Elephant feces Thailand AB727606 Lorliam et al. (unpublished)
Candida sp. 10-4 Elephant feces Thailand AB727608 Lorliam et al. (unpublished)
Candida sp. 10-5 Elephant feces Thailand AB727609 Lorliam et al. (unpublished)
Candida sp. 10-8 Elephant feces Thailand AB727610 Lorliam et al. (unpublished)
Candida sp. VITGBN1 Industrial wastewater India KC135883 Basak and Das (unpublished)
Candida sp. VITJzN04 Agricultural soil India JX454449 Salam and Das (unpublished)
Candida sp. D15 Insect Bulgaria HM627153 Gouliamova et al. (unpublished)
Candida sp. D24 Insect Bulgaria HM627160 Gouliamova et al. (unpublished)
Candida sp. Envir-L230 Environmental Brazil JX245057 Chaves et al. (2013)
Candida sp. Envir-L231 Environmental Brazil JX245058 Chaves et al. (2013)
Candida sp. DMic 103837 Catheter Argentina JF345209 Taverna et al. (2012)
Candida sp. DMic 103838 Catheter Argentina JF345210 Taverna et al. (2012)
Candida sp. DMic 103839 (CBS
12267)T
Human blood Argentina JF345211 Taverna et al. (2012)
Candida sp. DMic 103840 Human blood Argentina JF345212 Taverna et al. (2012)
Candida sp. DMic 103841 Human blood Argentina JF345213 Taverna et al. (2012)
Candida sp. DMic 103842 Human blood Argentina JF345214 Taverna et al. (2012)
C. pseudorugosa XH1164 (CBS
10433)T
Human sputum China DQ234792 Li et al. (2006)
C. pseudorugosa UTHSC 06-3641 Human catheter urine USA HE716755 Paredes et al. (2012)
C. pseudorugosa UTHSC 08-707 Human knee USA HE716756 Paredes et al. (2012)
C. neorugosa UTHSC 10-2054
(CBS12627)T
Human leg wound USA HE716762 Paredes et al. (2012)
C. neorugosa UTHSC 10-121 Horse leg wound USA HE716761 Paredes et al. (2012)
Candida sp. SK75 Human ulcerated
lesion
Brazila GQ176145 Mota et al. (unpublished)
C. rugosa (C. pararugosa) CBS1948T Human sputum Norway JX245060 Chaves et al. (2013)
C. pararugosa UTHSC 08-442 Human urine USA HE716757 Paredes et al. (2012)
C. pararugosa UTHSC 09-2953 Human vagina USA HE716758 Paredes et al. (2012)
C. pararugosa UWFP-348 Human USA AF335925 and
AF335965b
Chen et al. (2001)
C. pararugosa KKA Seq 1226 Human Germany EF519702 Forster et al. (unpublished)
C. pararugosa ATCC 38774T Human feces – AF421856 Chen et al. (2001)
C. pararugosa MA09-AP Cheese Canada GQ458032 Arteau et al. (2010)
C. pararugosa IDR1000011225 – USAa JN675331 Chaturvedi and Chaturvedi. (unpublished)
C. pararugosa ‘‘MOTA’’ Human oral cavity Brazila GQ139517 Mota et al. (unpublished)
C. pararugosa M 0166 Koumiss China EU780147 Chen. (unpublished)
C. pararugosa 3AD19 Cheese Spain DQ646685 Alvarez-Martin et al. (2007)
C. pararugosa ZIM 2433 Cheese Serbia HE799663 Cadez et al. (unpublished)
C. pararugosa ZIM 2438 Cheese Serbia HE799664 Cadez et al. (unpublished)
36 A.C.B. Padovan et al. / Fungal Genetics and Biology 61 (2013) 33–41
Table 1 (continued)
Strain Source/isolation site Country ITS GenBank no. References
C. parapsilosis L6492 Human blood Brazil EU564205 Gonçalves et al. (unpublished)
C. metapsilosis L7685 Human blood Brazil EU484054 Gonçalves et al. (unpublished)
C. orthopsilosis L7956 Human blood Brazil EU557373 Gonçalves et al. (unpublished)
C. dubliniensis IFM53163 Human sputum Japan AB369916 Sano et al. (unpublished)
C. albicans ZA046 Human oral China FJ662406 Zheng et al. (unpublished)
T Type strain.
a Country assigned by the location of the university or research center from which the sequence of the isolate was generated.
b ITS1-5.8S and 5.8S-ITS2 sequences merged into a single contig to be used in the phylogenetic analysis.
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nate (v), citrate (v), and hexadecane (late +).
The accuracy of phenotypic methods in the identiﬁcation of
species within the C. rugosa complex has been evaluated in new
studies comprising a limited number of strains. Overall, databases
of all commercial systems include only the C. rugosa taxon. By
checking the identiﬁcation of C. rugosa strains with API 20C, ID
32C and Vitek YBC, the rates of inconsistent results and/or
misidentiﬁcation ranged from 42% to 100% compared to DNA
sequencing (Cendejas-Bueno et al., 2010; Chaves et al., 2013;
Ciardo et al., 2006; Paredes et al., 2012).
Recently, Paredes et al. (2012) suggested a panel of four assim-
ilation tests that could discriminate C. rugosa, C. pseudorugosa and
C. neorugosa (Table 2). It is noteworthy that in that particular study,
only two strains representative of each species were tested, and no
single type strain was incorporated into the analysis. Moreover,
these data disagree with a previous publication by Meyer et al.
(1998) and the results found in our laboratory with the same
assimilation tests using the type strains (Table 2). In conclusion,
the validation of the Paredes and collaborators strategy for screen-
ing species within the C. rugosa complex should be conﬁrmed by
further studies enrolling a larger number of strains.3.3. Proteomics for species identiﬁcation within the C. rugosa complex
Together with DNA proﬁling, protein ﬁngerprinting has been
used to identify the genus and species of relevant microorganisms
in industrial and medical scenarios (Fox, 2006). Protein ﬁngerprint-
ing relies on matrix-assisted laser-desorption/ionization–time-
of-ﬂight mass spectrometry (MALDI-TOF MS), in which proteins
within a complex mixture are analyzed in less than 2 min. Mass
spectra of the most abundant proteins of the isolate in culture
range from 1000 to 20,000 Da. The ﬁnal genus or species identiﬁca-
tion is provided by comparisons of peaks from ﬁngerprints
deposited in a curated library with peaks of the spectrum gener-
ated from the sample (Bruker and Daltonics, 2008).
The libraries widely used to identify species by MALDI-TOF
technology, e.g., BioTyper (Bruker Daltonics, Bremen, Germany)
and SARAMIS (bioMérieux, Potsdam-Golm, Germany), contain the
spectra of C. rugosa and C. pararugosa, but none of them is up to
date with the novel taxonomic classiﬁcation of the C. rugosa spe-
cies complex (Bruker and Daltonics, 2008; Saramis, 2009).
Marklein et al. (2009) tested the accuracy of MALDI-TOF MS
identiﬁcation compared with conventional tests. They tested 285
isolates from medically important yeasts, and 92.5% (247) of the
isolates were accurately identiﬁed by proteomics. The remaining
isolates were later identiﬁed after complementation of the data-
base with protein spectra of the missing type strains. The single
C. rugosa isolate tested in the paper was accurately identiﬁed after
the database complementation was completed (Marklein et al.,
2009).
In 2010, Stevenson and collaborators created a spectral data-
base library using the MALDI BioTyper2 software (BrukerDaltonics) for 109 type strains. Afterwards, 194 clinical isolates
belonging to 23 species of six genera were tested. They reported
an identiﬁcation accuracy of 99.0% (192 isolates), including six
C. rugosa isolates with spectral scoreP1.8. The two clinical isolates
that were not identiﬁed were one C. rugosa and one Cryptococcus
neoformans, which may reﬂect the heterogeneity of isolates within
the C. rugosa species complex (Stevenson et al., 2010).
In the present study, we report the proﬁles generated by
MALDI-TOF MS analysis of six reference strains and four clinical
isolates representative of the C. rugosa species complex. The most
representative spectrum proﬁles that differentiated the species of
the isolates presented peaks ranging from 2000 to 10,000 Da, with
two regions with the most intense peaks at 3000–4000 and 6000–
8000 Da (Fig. 3). Fig. 3 depicts the dendrogram that successfully
discriminated all type strains from the different species tested
and grouped the 5 isolates belonging to the novel C. mesorugosa
species. Despite we used a few isolates, proteomic data corroborate
our phylogenetic analysis using ITS sequences and also conﬁrm the
intraspecies variations of C. mesorugosa strains isolated from differ-
ent regions of Brazil, as previously observed by our group using
RAPD and multilocus analyses (Chaves et al., 2013).
Taking the above results together, we conclude the molecular
identiﬁcation of the C. rugosa species complex at the species level
may be achieved by using MALDI-TOF MS and ITS region sequenc-
ing analyses.3.4. Considerations on the clinical aspects related to C. rugosa complex
Despite being considered a rare human pathogen, there are
several reports of cluster episodes of fungemia due to C. rugosa
documented in patients admitted to intensive care units. According
to Minces et al. (2009), a total of 27 episodes of candidemia were
reported in the English literature since its ﬁrst description in
1985, including an outbreak of six cases in Brazil and a large series
of invasive candidiasis documented in burn patients in California
(Colombo et al., 2003; Dube et al., 1994; Minces et al., 2009; Rein-
hardt et al., 1985; Sugar and Stevens, 1985). Recently, Behera et al.
(2010) reported an additional cluster of fungemia due to C. rugosa
in 19 critically ill trauma patients in a teaching hospital of north
India.
Considering the epidemiological data provided by the three
largest series of candidemia mentioned above, we may suggest
that the main conditions associated with episodes of C. rugosa fun-
gemia are tegument disruption by invasive medical procedures or
burns as well as previous exposure to nystatin, parenteral nutrition
and broad-spectrum antibiotics (Behera et al., 2010; Colombo
et al., 2003; Dube et al., 1994). Of note, a substantial number of
cases have been documented in patients older than 60 years, as
noted by Tay et al. (2011) in their report of two cases of fungemia
(Tay et al., 2011).
Indeed, there is much controversy about the in vitro susceptibil-
ity of strains of the C. rugosa complex to antifungal drugs. Pfaller
et al. (2006) found that only 40% of 462 C. rugosa strains tested
Fig. 1. Unrooted Bayesian consensus phylogenetic tree of the Candida rugosa species complex and other Candida spp. based on conﬁdently aligned ITS rDNA sequences (Table 1). Posterior probabilities above 0.75 are depicted in
the main nodes. The Bayesian tree was inferred from 2.5 million generations with burn-in = 6250. Runs were saved every 100 generations and run in four chains and two runs. The selected model was fA = 0.296757, fC = 0.216826,
fG = 0.206238, and fT = 0.280179, with rate matrix [A–C] = 0.133394, [A–G] = 0.225850, [A–T] = 0.156289, [C–G] = 0.111998, [C–T] = 0.265260 and [G–T] = 0.107209. The shape parameter of the gamma distribution was
a = 0.389278, and the proportion of invariant sites was I = 0.019057.
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Fig. 2. (A and B) Macromorphology of colonies from (I) C. rugosa ATCC 10571T, (II) C. mesorugosa CBS 12656T, (III) C. pseudorugosa CBS 10433T, (IV) C. rugosa (C. pararugosa)
CBS 1948T and (V) C. neorugosa CBS 12627T type strains grown on SDA and CHROMagar Candida, respectively. Micromorphology of cells grown in YPD broth (left column) and
on cornmeal agar (right column), with 400X magniﬁcation. Letters identify respectively: (C and D) C. rugosa ATCC 10571T; (E and F) C. mesorugosa CBS 12656T; (G and H) C.
pseudorugosa CBS 10433T; (I and J) C. rugosa (C. pararugosa) CBS 1948T; and (K and L) C. neorugosa CBS 12627T.
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nazole. In a previous series reported by our group, three of six
patients were infected by strains exhibiting high MIC’s againstﬂuconazole (Colombo et al., 2003). Behera et al. (2010) tested 19
strains and found only 20% of them with high MIC’s to ﬂuconazole,
though all them exhibited low MIC’s to amphotericin B and voric-
Table 2
Assimilation tests proposed for identiﬁcation of the C. rugosa species complex. Results obtained by different authors.
Authors
Paredes et al. (2012) Present studya Meyer et al. (1998)
Species C. rug C. neo C. pse C. mes C. rug C. neo C. pse C. mes C. rugosa sensu lato
Carbon sources
SOR + +  NT + + + + v
XYL + +  NT + + + + v
RIB  +  NT  +   
GLY + +  NT + +  + +
a The present study tested only type strain isolates from each species C. rug: C. rugosa; C. neo: C. neorugosa; C. pse: C. pseudorugosa; C. mes: C. mesorugosa SOR: Sorbose; XYL:
D-xylose; RIB: ribitol; GLY: glycerol +: positive; : negative; v: variable; NT: Not tested.
C. mesorugosa L412D
C. mesorugosa L387A
C. mesorugosa L69D (CBS 12656)T
C. mesorugosa L154 
C. mesorugosa L2683B
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C. pseudorugosa CBS 10433T
C. neorugosa CBS 12627T
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Fig. 3. Dendrogram of the main spectra of the C. rugosa species complex and C. albicans and C. pararugosa reference strains. Distance values are relative and normalized to a
maximum value of 1000. In detail, representative spectra from the isolates analyzed in this study. m/z: mass to charge ratio.
40 A.C.B. Padovan et al. / Fungal Genetics and Biology 61 (2013) 33–41onazole. Paredes et al. (2012) tested 10 strains of C. rugosa sensu
stricto and found that all presented low MIC’s to triazoles, ampho-
tericin B and candins.
Finally, based on the large discrepancies in the results described
by different studies, it is possible that there is a high variability of
antifungal MIC’s within strains of the C. rugosa complex that may
be related to geographic variations as well as inter- and intraspe-
cies variations. Consequently, based on the uncertainty of the best
therapeutic choice for treating invasive infections of C. rugosa, deci-
sions on antifungal therapy should be made case by case, consider-ing the accurate species identiﬁcation, clinical status of the patient,
the site of infection and the in vitro antifungal susceptibility of the
particular isolate.
4. Conclusions
The accurate identiﬁcation of the four species within the
C. rugosa complex and C. pararugosa is highly dependent on molec-
ular methods. Here we showed that ITS sequencing analysis
appears to be the most reliable for identiﬁcation and proteomics
A.C.B. Padovan et al. / Fungal Genetics and Biology 61 (2013) 33–41 41has a potential to discriminate species within the C. rugosa com-
plex. Our phylogenetic analysis using ITS sequences were adequat-
ed for phylogenetic and evolutionary analyses, which consolidated
the four taxa within the C. rugosa complex as distinct species and
also demonstrated high diversity among the isolates within each
clade, which may reﬂect an ongoing diversiﬁcation process. Finally,
we propose that collaborative and multicentric studies enrolling
medical centers from different geographic areas are needed to
investigate the putative biological differences and clinical features
of infections caused by each species of the C. rugosa complex, as
well as to validate new, reliable diagnostic tools and therapeutic
strategies.
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